Design Therapeutics, Inc.DSGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank87
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P87
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 20255.91%
Q3 202510.47%
Q2 2025-5.64%
Q1 2025-22.31%
Q4 2024-2.76%
Q3 2024-8.00%
Q2 2024-4.47%
Q1 20244.77%
Q4 202319.66%
Q3 202316.70%
Q2 2023-4.36%
Q1 2023-11.65%
Q4 2022-1.04%
Q3 2022-22.72%
Q2 2022-16.97%
Q1 2022-20.16%
Q4 20211.85%
Q3 2021-47.48%
Q2 2021-35.33%
Q1 2021-47.11%
Q4 2020-62.02%
Q3 2020-62.88%
Q2 2020-134.83%
Q1 20200.00%